For research teamsHelp me find a study
Back to all studies
CompletedNCT02953639

Basmisanil for schizophrenia

This study is completed in the United States. It is testing basmisanil for schizophrenia.

SchizophreniaDrugFrom 18 Years to 50 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore recruiting studies on this topic

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether Basmisanil may be useful for adults experiencing schizophrenia.

What would participation involve?

Participants may receive Basmisanil, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in the United States.

Who is it mainly for?

This study appears to be mainly for adults with schizophrenia.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: November 30, 2016
Recruitment status
Completed
Enrollment listed in the registry
214
Sponsor
Hoffmann-La Roche
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 50 Years
Official registry ID
NCT02953639
Official title
A Phase IIb, Multicenter, Randomized, Double-Blind, Parallel Group, Placebo Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Basmisanil (RO5186582) as Adjunctive Treatment in Patients With Cognitive Impairment Associated With Schizophrenia Treated With Antipsychotics

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

United States · 37 sites
  • Woodland International Research Group Inc.
    Little Rock, Arkansas
    Site status: Not listed — confirm with the team
  • Woodland Research Northwest, LLC
    Rogers, Arkansas
    Site status: Not listed — confirm with the team
  • ProScience Research Group
    Culver City, California
    Site status: Not listed — confirm with the team
  • Collaborative Neuroscience Network, Inc.
    Garden Grove, California
    Site status: Not listed — confirm with the team
  • California Clinical Trials
    Glendale, California
    Site status: Not listed — confirm with the team
  • Alliance for Wellness, dba Alliance for Research
    Long Beach, California
    Site status: Not listed — confirm with the team
  • Synergy Clinical Research
    National City, California
    Site status: Not listed — confirm with the team
  • Pacific Research Partners, LLC
    Oakland, California
    Site status: Not listed — confirm with the team
  • NRC Research Institute
    Orange, California
    Site status: Not listed — confirm with the team
  • CNRI - Los Angeles, LLC
    Pico Rivera, California
    Site status: Not listed — confirm with the team
  • Artemis Institute for Clinical Research, LLC
    San Diego, California
    Site status: Not listed — confirm with the team
  • Collaborative Neuroscience Network Inc.
    Torrance, California
    Site status: Not listed — confirm with the team
  • Yale School of Medicine - CT Mental Health Center (CMHC) - Schizophrenia Research Clinic
    New Haven, Connecticut
    Site status: Not listed — confirm with the team
  • Vantage Clinical Trials
    Largo, Florida
    Site status: Not listed — confirm with the team
  • Innovative Clinical Research, Inc.
    Lauderhill, Florida
    Site status: Not listed — confirm with the team
  • Meridien Research
    Maitland, Florida
    Site status: Not listed — confirm with the team
  • University of Miami Dept of Psychiatry
    Miami, Florida
    Site status: Not listed — confirm with the team
  • Behavioral Clinical Research, Inc.
    North Miami, Florida
    Site status: Not listed — confirm with the team
  • iResearch Atlanta
    Decatur, Georgia
    Site status: Not listed — confirm with the team
  • Alexian Brothers Center for Psychiatric Research
    Hoffman Estates, Illinois
    Site status: Not listed — confirm with the team
  • Community Clinical Research Center
    Anderson, Indiana
    Site status: Not listed — confirm with the team
  • Booker, J. Gary, MD, APMC
    Shreveport, Louisiana
    Site status: Not listed — confirm with the team
  • Louisiana Clinical Research, LLC
    Shreveport, Louisiana
    Site status: Not listed — confirm with the team
  • CBH Health
    Gaithersburg, Maryland
    Site status: Not listed — confirm with the team
  • Boston Medical Center
    Boston, Massachusetts
    Site status: Not listed — confirm with the team
  • Arch Clinical Trials, LLC
    St Louis, Missouri
    Site status: Not listed — confirm with the team
  • St Louis Clinical Trials
    St Louis, Missouri
    Site status: Not listed — confirm with the team
  • Hassman Research Institute
    Berlin, New Jersey
    Site status: Not listed — confirm with the team
  • Neurobehavioral Research, Inc.
    Cedarhurst, New York
    Site status: Not listed — confirm with the team
  • Manhattan Psychiatric Center; Psychopharmacology Research Unit
    New York, New York
    Site status: Not listed — confirm with the team
  • Finger Lakes Clinical Research
    Rochester, New York
    Site status: Not listed — confirm with the team
  • Neuro-Behavioral Clinical Research, Inc.
    Canton, Ohio
    Site status: Not listed — confirm with the team
  • University Hospitals
    Cleveland, Ohio
    Site status: Not listed — confirm with the team
  • Midwest Clinical Research Center
    Dayton, Ohio
    Site status: Not listed — confirm with the team
  • Pillar Clinical Research LLC
    Garland, Texas
    Site status: Not listed — confirm with the team
  • University Hills Clinical Research - Irving;Office of Dr. Knesevich
    Irving, Texas
    Site status: Not listed — confirm with the team
  • Northwest Clinical Research Center
    Bellevue, Washington
    Site status: Not listed — confirm with the team

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT02953639. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving Basmisanil, Placebo. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.

Who might this study be for?

This study may concern people with schizophrenia; age range: From 18 Years to 50 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Hoffmann-La Roche, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.